Weijun Cheng has an extensive background in pharmaceutical product development, with experience at ANI Pharmaceuticals, Inc. as a Director overseeing API and drug product manufacturing activities. They also have experience at Arrowhead Pharmaceuticals as a Senior Scientist working on targeted delivery of siRNA drugs. Weijun holds a Ph.D. in Physiology from the University of Wisconsin-Madison and a BS in Biology from Fudan University.
March 1, 2024 - present
May, 2020
May, 2017